Confo Therapeutics Establishes Medical Advisory Board
Confo Therapeutics announced the establishment of its Medical Advisory Board (MAB). It will be chaired by Andrew Rice. The other members include, Ralf Baron, Robert H. Dworkin, Nanna Brix Finnerup, Nathaniel Katz, Andrew S.C. Rice, and Mark Versavel.
Confo Therapeutics’ unparalleled technology stabilizes functional conformations of GPCRs (G protein-coupled receptors) to uncover a wide range of previously inaccessible GPCRs as drug targets. The company is based in Belgium.